A pilot study of two regimens of intermittent thiacetazone plus isoniazid in the treatment of pulmonary tuberculosis in East Africa.
D000293:Adolescent; D000351:Africa, Eastern; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000628:therapy; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000008:administration & dosage / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin